8 The Grn, Ste. A, Dover, DE 19901
customersupport@gobymeds.com
+1 866 785 9869
Copyright ©2026 GobyMeds
Get Started
All payments are securely processed and transferred via SSL encryption
All transactions are conducted in USD
Consent to Telemedicine and Informed Consent for Medications
Last Updated: June 17th, 2026
=
Please read this document thoroughly, including the consent to compounded and prescription medications below, which addresses important risks and benefits of these medications.
By using the GobyMeds platform, your telemedicine visits will be furnished by one of GobyMeds' independent medical groups participating in the GobyMeds provider network— Beluga Health, P.A. (“Beluga”) or CareValidate, Inc., including its affiliated professional entities (“CareValidate”) - through a healthcare practitioner licensed or otherwise authorized to provide care in the state where you are physically located at the time of the telemedicine encounter. GobyMeds itself does not provide medical care, prescribe, or dispense medications. The medical group that furnishes your care is determined by GobyMeds' provider network and may vary; you may not be able to select your provider. Telemedicine encounters may occur through asynchronous questionnaires, secure messaging, phone, video, or other legally permitted technologies, depending on the service, the patient’s location, provider judgment, and applicable law. Certain services, including controlled-substance evaluations, may require real-time audio-video interaction, identity and location verification, laboratory testing, PDMP review, in-person care, or other steps before treatment may be prescribed or continued. The services of GobyMeds and participating providers are available only in states where the applicable provider is licensed and where applicable law permits, and you must be physically located in such a state at the time of care. Your provider may determine that telemedicine is not appropriate for your condition and may require in-person evaluation, additional records, labs, imaging, specialist consultation, or emergency care. GobyMeds and participating providers do not provide emergency medical services. If you believe you are experiencing a medical emergency, call 911 or go to the nearest emergency room. Telemedicine may not be appropriate for urgent or emergency conditions, and your provider may direct you to seek in-person care.
Additional Telemedicine Disclosures. Before clinical services are furnished, the identity, credentials, and licensure information of your treating provider or applicable medical group will be made available through your account, visit communications, clinical documentation, prescription or lab order, or upon request. Telemedicine may involve risks, including technology failures, delays, incomplete or inaccurate information, limited physical examination, and privacy or security limitations despite reasonable safeguards. You are responsible for using the services from a private location when possible and for protecting your account credentials. Alternatives to telemedicine may include in-person care, seeking care from another provider, or declining telemedicine services. You may withdraw your consent to telemedicine at any time by stopping use of the services or contacting GobyMeds, but withdrawal will not affect care already provided, records already created, communications legally permitted or required, or payment obligations already incurred. You may request access to your medical records by contacting GobyMeds support or the medical group that furnished your care.
By clicking the checkbox agreeing to these terms during your GobyMeds account creation, checkout, intake, or other applicable consent workflow, you consent to receive telemedicine services through the GobyMeds provider network, which may include Beluga Health, P.A. (“Beluga”) or CareValidate, Inc., including its affiliated professional entities (“CareValidate”). Your assigned medical group and treating provider may be determined based on your location, the service requested, provider licensure, clinical judgment, operational availability, and applicable law, and may vary during your use of the services. Because either medical group may furnish your care, you agree to the telemedicine and medical consent terms of each medical group to the extent applicable to services furnished by that medical group: the Beluga Asynchronous Telemedicine Informed Consent, located here, and the CareValidate Medical Consent, which includes CareValidate’s Telehealth Consent, located here. If you do not agree to these terms, you should not use the GobyMeds platform for telemedicine services.
BY CONTINUING TO USE GOBYMEDS’ PLATFORM AND SERVICES, I ASSERT THAT I HAVE READ AND UNDERSTAND THE TERMS PRESENTED OR LINKED TO HEREIN AND GIVE MY INFORMED CONSENT TO PARTICIPATE IN TELEMEDICINE, WHICH MAY INCLUDE ASYNCHRONOUS QUESTIONNAIRES, SECURE MESSAGING, PHONE, VIDEO, OR OTHER LEGALLY PERMITTED TECHNOLOGIES, DEPENDING ON THE SERVICE, MY LOCATION, PROVIDER JUDGMENT, AND APPLICABLE LAW.
The partner consents linked above describe certain clinical and privacy practices of the medical group that furnishes your care. For any order you place through GobyMeds, GobyMeds' Terms of Service — including its Payment and Billing and Refund provisions — govern all billing, charges, renewals, and refunds. GobyMeds offers single-payment-per-order pricing and does not enroll you in any auto-renewing or subscription program. To the extent a linked partner consent contains terms addressing automatic renewal, recurring charges, keeping a payment card on file, no-refund conditions, or agreements not to dispute charges, those terms describe that partner's own direct services and do not apply to orders placed through GobyMeds.
During your telemedicine visit, a licensed provider will evaluate your medical history, medications, and other information to determine whether a prescription medication offered through the platform (which may include compounded medication) is appropriate for you. Our Safety Information page, located here, contains links to Important Safety Information about compounded and name-brand drugs that may be prescribed through the GobyMeds platform, including potential benefits and risks of these drugs. This information is provided for informational purposes and as a convenience and does not replace medical advice from your treating provider or counseling from your pharmacy.
Medication-specific risks, contraindications, boxed warnings, limitations of use, dosing instructions, storage requirements, and emergency symptoms may vary by medication and formulation. You agree to review the safety information applicable to the specific medication prescribed to you and to contact your provider or pharmacy with questions before starting treatment.
Compounded medications are prepared by a pharmacy or outsourcing facility and are not reviewed by FDA for safety, effectiveness, or quality before dispensing. Compounded medications may differ from FDA-approved medications in formulation, concentration, inactive ingredients, dosing devices, storage requirements, and labeling. Compounded medications are not generic versions of FDA-approved medications and should not be understood to be identical to, interchangeable with, or clinically equivalent to any FDA-approved medication. Availability of compounded medications may change based on federal or state law, FDA shortage determinations, pharmacy requirements, or provider judgment. You should carefully follow the dosing and administration instructions provided and ask your provider or pharmacy if you are unsure how to measure or administer a dose.
It is your responsibility to review and consider the applicable safety information and to ask your provider or pharmacy any questions before starting treatment with these or any medications.
By clicking the checkbox agreeing to these terms during your GobyMeds account creation, you acknowledge and agree to the following:
• You have read and understand the potential side effects and risks.
• You understand that GobyMeds services are limited in scope and do not replace comprehensive primary care, urgent care, emergency care, or ongoing care for conditions outside the services requested. You are encouraged to maintain an ongoing relationship with a primary care provider.
• There are no guarantees of weight loss or other treatment results.
• Compounded medications are not FDA-approved.
• You will truthfully disclose all health information requested.
• You will follow dosage and administration instructions and not share needles.
Some lab testing services offered through GobyMeds may be facilitated by Junction / Adept Labs and its affiliated provider network, including OpenLoop Healthcare Partners and related professional entities. If you use these lab testing services, you acknowledge and agree to the following:
• Lab-related telehealth consultations may take place by video, phone, or asynchronous technology, and the provider will not be physically present with you.
• Telehealth technology carries risks, including interruptions, delays, unauthorized access, or technical failure.
• Either the provider or you may discontinue the telehealth interaction if the connection is inadequate.
• You understand that you could seek in-person care instead of using telehealth or lab testing facilitated through Junction.
• You agree to complete any telehealth or lab-related interaction from a private location, and you understand the provider will do the same.
• You are responsible for any amounts due related to the lab testing and related telehealth services.
• In an emergency, the telehealth provider may direct you to emergency medical services, including an emergency room.
• You certify that you have read this consent or had it explained to you, that you understand the risks and benefits, and that you have had the opportunity to ask questions.
• You understand that failing to complete required labs or follow-up may delay, pause, or prevent treatment. Abnormal lab results may require additional evaluation, referral to in-person care, medication changes, or discontinuation. Lab testing ordered through the platform is not a substitute for emergency care or a comprehensive primary-care evaluation.
Additional terms governing these lab testing services are set out in the Junction / OpenLoop Telehealth Consent Form, located here. Please review it before using these services.
If you are evaluated for or prescribed testosterone replacement therapy (TRT) or another controlled-substance medication through the platform, you acknowledge and agree that:
• Testosterone is a federally controlled substance (Schedule III), and treatment is subject to additional federal and state requirements. Controlled-substance treatment via telemedicine is available only where permitted by applicable federal and state law and may not be available in all states.
• Your provider may require laboratory testing and ongoing monitoring before and/or during treatment and may decline to prescribe based on clinical judgment.
• TRT is not appropriate for everyone and is not guaranteed to improve symptoms. TRT is generally considered only when your provider determines that you have symptoms or signs consistent with testosterone deficiency and qualifying laboratory results; it is not prescribed through the platform for bodybuilding, athletic performance, anti-aging alone, or fertility enhancement. You may be required to complete identity and location verification, Prescription Drug Monitoring Program (PDMP) checks, real-time audio/video or other legally required telehealth interactions, baseline and follow-up laboratory testing, blood pressure checks, and follow-up visits. Monitoring may include testosterone levels, CBC/hematocrit, PSA or other prostate-risk assessment when clinically indicated, and other labs or assessments determined by your provider. TRT may cause or worsen increased red blood cell count/hematocrit, blood clots, increased blood pressure, fluid retention, acne or oily skin, hair loss, breast tenderness or enlargement, mood changes,
sleep apnea, urinary or prostate symptoms, changes in cholesterol or liver markers, injection-site reactions, reduced sperm production, testicular shrinkage, or infertility, which may be prolonged or irreversible. You must tell your provider if you have or have had prostate or breast cancer, elevated PSA or prostate abnormality, high hematocrit, a clotting disorder, untreated sleep apnea, severe urinary symptoms, uncontrolled heart failure or hypertension, recent heart attack or stroke, liver, kidney, or heart disease, depression or mood disorder, or if you are trying to conceive. You agree to use TRT only as prescribed, not to share, sell, misuse, or transfer it, to store it securely away from others, and to promptly report serious symptoms such as chest pain, shortness of breath, leg swelling or pain, severe headache, vision changes, fainting, severe mood or behavior changes, signs of allergic reaction, or concerning urinary/prostate symptoms. Missed monitoring, unsafe lab results, inaccurate disclosures, suspected misuse or diversion, legal or pharmacy restrictions, or your provider’s clinical judgment may result in dose changes, treatment pauses, non-renewal, discontinuation, or denial of treatment.
Certification of Consent to Proceed with Treatment
You acknowledge that you have reviewed the information provided, understand the material risks, benefits, and alternatives described, have had the opportunity to ask questions, and consent to proceed with evaluation and, if prescribed by your provider, treatment. Nothing in this consent limits or waives any rights you may have under applicable law.
You consent to GobyMeds, its healthcare practitioners, and participating medical partners contacting you by calls, emails, SMS, or MMS regarding your account, treatment, appointments, prescriptions, labs, pharmacy coordination, safety issues, and other matters related to your telemedicine services, using the contact information you provide. These communications may include Personal Information or Sensitive Information as described in the GobyMeds Privacy Policy and may be sent using automated technology or prerecorded/artificial voice where permitted by law. Standard carrier rates may apply. You may withdraw consent to treatment-related text messages by following the opt-out instructions provided in the message, replying STOP where available, emailing customersupport@gobymeds.com, or using any other reasonable method.
This Telemedicine Informed Consent remains valid throughout your treatment with GobyMeds.
We may update this Notice from time to time. When required by law or when we make material changes affecting your treatment, consent, privacy, payment obligations, medication risks, telehealth rights, or dispute-related terms, we may require your renewed review and acceptance before you continue using applicable services.
.svg)